TABLE OF CONTENTS
1 INTRODUCTION
1.1 OBJECTIVES OF THE STUDY
1.2 MARKET DEFINITION
1.3 OVERVIEW OF NORTH AMERICA MULTIPLEX ASSAYS MARKET
1.4 CURRENCY AND PRICING
1.5 LIMITATION
1.6 MARKETS COVERED
2 MARKET SEGMENTATION
2.1 MARKETS COVERED
2.2 GEOGRAPHIC SCOPE
2.3 YEARS CONSIDERED FOR THE STUDY
2.4 CURRENCY AND PRICING
2.5 RESEARCH METHODOLOGY
2.6 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS
2.7 DBMR MARKET POSITION GRID
2.8 DBMR MARKET CHALLENGE MATRIX
2.9 THE CATEGORY VS TIME GRID
2.10 SECONDARY SOURCES
2.11 ASSUMPTIONS
3 MARKET OVERVIEW
3.1 DRIVERS
3.1.1 USE OF MULTIPLEX ASSAYS IN COMPANION DIAGNOSTICS
3.1.2 ADVANTAGES OVER SINGLEPLEX AND TRADITIONAL ASSAYS
3.1.3 INCREASING AWARENESS ABOUT MULTIFACTORIAL NATURE OF VARIOUS DISEASES
3.1.4 GROWING APPLICATIONS OF MULTIPLEX ASSAYS
3.2 RESTRAINTS
3.2.1 HIGH EQUIPMENT COSTS
3.2.2 STRINGENT REGULATIONS AND STANDARDS
3.3 OPPORTUNITIES
3.3.1 INCREASING VALIDATION OF BIOMARKERS IN MOLECULAR AND PROTEIN DIAGNOSTICS
3.3.2 NEWLY AVAILABLE OR LAUNCHED PANELS FOR THE ASSAYS
3.4 CHALLENGES
3.4.1 LACK OF PROFICIENT LABOUR TO HANDLE ADVANCED PROCEDURES
4 EXECUTIVE SUMMARY
5 PREMIUM INSIGHTS
6 NORTH AMERICA MULTIPLEX ASSAYS MARKET, BY PRODUCT & SERVICES
6.1 OVERVIEW
6.2 REAGENTS & CONSUMABLES
6.3 INSTRUMENTS & ACCESSORIES
6.4 SOFTWARE & SERVICES
7 NORTH AMERICA MULTIPLEX ASSAYS MARKET, BY TYPE
7.1 OVERVIEW
7.2 NUCLEIC ACID MULTIPLEX ASSAYS
7.2.1 PLANAR NUCLEIC ASSAYS
7.2.2 BEAD-BASED NUCLEIC ASSAYS
7.3 PROTEIN MULTIPLEX ASSAYS
7.3.1 PLANAR PROTEIN ASSAYS
7.3.2 BEAD-BASED PROTEIN ASSAYS
7.4 CELL-BASED MULTIPLEX ASSAYS
8 NORTH AMERICA MULTIPLEX ASSAYS MARKET, BY TECHNOLOGY
8.1 OVERVIEW
8.2 PROTEIN MICROARRAY
8.3 POLYMERASE CHAIN REACTION
8.4 MULTIPLEX REAL-TIME PCR
8.5 FLOW CYTOMETRY
8.6 FLUORESCENCE DETECTION
8.7 LUMINESCENCE
8.8 OTHERS
9 NORTH AMERICA MULTIPLEX ASSAYS MARKET, BY APPLICATION
9.1 OVERVIEW
9.2 CLINICAL DIAGNOSTICS
9.2.1 CANCER
9.2.2 CARDIOVASCULAR DISEASES
9.2.3 METABOLISM & ENDOCRINOLOGY DISORDERS
9.2.4 INFECTIOUS DISEASES
9.2.5 NERVOUS SYSTEM DISORDERS
9.2.6 AUTOIMMUNE DISEASES
9.2.7 ALLERGIES
9.2.8 OTHERS
9.3 RESEARCH & DEVELOPMENT
9.3.1 DRUG DISCOVERY & DEVELOPMENT
9.3.2 BIOMARKER DISCOVERY & VALIDATION
10 NORTH AMERICA MULTIPLEX ASSAYS MARKET, BY END USER
10.1 OVERVIEW
10.2 HOSPITALS
10.3 CLINICAL LABORATORIES
10.4 PHARMACEUTICAL & BIOTECHNOLOGY COMPANIE
10.5 RESEARCH INSTITUTES
10.6 OTHERS
11 NORTH AMERICA MULTIPLEX ASSAYS MARKET; BY GEOGRAPHY
11.1 NORTH AMERICA
11.1.1 U.S.
11.1.2 CANADA
11.1.3 MEXICO
12 NORTH AMERICA MULTIPLEX ASSAYS MARKET, COMPANY LANDSCAPE
12.1 COMPANY SHARE ANALYSIS; NORTH AMERICA
13 COMPANY PROFILE
13.1 THERMO FISHER SCIENTIFIC INC.
13.1.1 COMPANY SNAPSHOT
13.1.2 REVENUE ANALYSIS
13.1.3 COMPANY SHARE ANALYSIS
13.1.4 PRODUCT PORTFOLIO
13.1.5 RECENT DEVELOPMENTS
13.2 F. HOFFMANN-LA ROCHE LTD
13.2.1 COMPANY SNAPSHOT
13.2.2 REVENUE ANALYSIS
13.2.3 COMPANY SHARE ANALYSIS
13.2.4 PRODUCT PORTFOLIO
13.2.5 RECENT DEVELOPMENTS
13.3 BIO-RAD LABORATORIES, INC.
13.3.1 COMPANY SNAPSHOT
13.3.2 REVENUE ANALYSIS
13.3.3 COMPANY SHARE ANALYSIS
13.3.4 PRODUCT PORTFOLIO
13.3.5 RECENT DEVELOPMENTS
13.4 QIAGEN
13.4.1 COMPANY OVERVIEW
13.4.2 REVENUE ANALYSIS
13.4.3 COMPANY SHARE ANALYSIS
13.4.4 PRODUCT PORTFOLIO
13.4.5 RECENT DEVELOPMENTS
13.5 SIEMENS AG
13.5.1 COMPANY SNAPSHOT
13.5.2 REVENUE ANALYSIS
13.5.3 PRODUCT PORTFOLIO
13.5.4 RECENT DEVELOPMENTS
13.6 ABCAM PLC.
13.6.1 COMPANY SNAPSHOT
13.6.2 REVENUE ANALYSIS
13.6.3 PRODUCT PORTFOLIO
13.6.4 RECENT DEVELOPMENTS
13.7 AGENA BIOSCIENCE, INC.
13.7.1 COMPANY SNAPSHOT
13.7.2 GEOGRAPHICAL PRESENCE
13.7.3 PRODUCT PORTFOLIO
13.7.4 RECENT DEVELOPMENTS
13.8 AGILENT TECHNOLOGIES, INC.
13.8.1 COMPANY SNAPSHOT
13.8.2 REVENUE ANALYSIS
13.8.3 PRODUCT PORTFOLIO
13.8.4 RECENT DEVELOPMENTS
13.9 BD.
13.9.1 COMPANY SNAPSHOT
13.9.2 REVENUE ANALYSIS
13.9.3 PRODUCT PORTFOLIO
13.9.4 RECENT DEVELOPMENTS
13.10 BIO-TECHNE.
13.10.1 COMPANY SNAPSHOT
13.10.2 REVENUE ANALYSIS
13.10.3 PRODUCT PORTFOLIO
13.10.4 RECENT DEVELOPMENTS
13.11 BIOTEK INSTRUMENTS, INC.
13.11.1 COMPANY SNAPSHOT
13.11.2 GEOGRAPHICAL PRESENCE
13.11.3 PRODUCT PORTFOLIO
13.11.4 RECENT DEVELOPMENTS
13.12 HOLOGIC INC.
13.12.1 COMPANY SNAPSHOT
13.12.2 REVENUE ANALYSIS
13.12.3 PRODUCT PORTFOLIO
13.12.4 RECENT DEVELOPMENTS
13.13 ILLUMINA, INC.
13.13.1 COMPANY SNAPSHOT
13.13.2 REVENUE ANALYSIS
13.13.3 PRODUCT PORTFOLIO
13.13.4 RECENT DEVELOPMENTS
13.14 LUMINEX CORPORATION.
13.14.1 COMPANY SNAPSHOT
13.14.2 REVENUE ANALYSIS
13.14.3 PRODUCT PORTFOLIO
13.14.4 RECENT DEVELOPMENTS
13.15 MESO SCALE DIAGNOSTICS, LLC.
13.15.1 COMPANY SNAPSHOT
13.15.2 PRODUCT PORTFOLIO
13.15.3 RECENT DEVELOPMENTS
13.16 OLINK
13.16.1 COMPANY SNAPSHOT
13.16.2 GEOGRAPHICAL PRESENCE
13.16.3 PRODUCT PORTFOLIO
13.16.4 RECENT DEVELOPMENTS
13.17 PERKINELMER INC.
13.17.1 COMPANY SNAPSHOT
13.17.2 REVENUE ANALYSIS
13.17.3 PRODUCT PORTFOLIO
13.17.4 RECENT DEVELOPMENTS
13.18 QUANTERIX
13.18.1 COMPANY SNAPSHOT
13.18.2 REVENUE ANALYSIS
13.18.3 PRODUCT PORTFOLIO
13.18.4 RECENT DEVELOPMENTS
13.19 QUEST DIAGNOSTICS INCORPORATED.
13.19.1 COMPANY SNAPSHOT
13.19.2 REVENUE ANALYSIS
13.19.3 PRODUCT PORTFOLIO
13.19.4 RECENT DEVELOPMENTS
13.20 RANDOX LABORATORIES LTD.
13.20.1 COMPANY SNAPSHOT
13.20.2 GEOGRAPHICAL PRESENCE
13.20.3 PRODUCT PORTFOLIO
13.20.4 RECENT DEVELOPMENTS
13.21 SEEGENE INC.
13.21.1 COMPANY SNAPSHOT
13.21.2 REVENUE ANALYSIS
13.21.3 PRODUCT PORTFOLIO
13.21.4 RECENT DEVELOPMENTS
13.22 SYSMEX CORPORATION
13.22.1 COMPANY SNAPSHOT
13.22.2 REVENUE ANALYSIS
13.22.3 PRODUCT PORTFOLIO
13.22.4 RECENT DEVELOPMENTS
14 RELATED REPORTS